Find Clinical Trials | Cedars-Sinai

153 results found

Other Female Genital, Other Male Genital, Ovary, Soft Tissue

Active Surveillance for Low Risk and Trial of Carboplatin vs. Cisplatin for Standard Risk Patients with Germ Cell Tumors

This study focuses on patients who have been diagnosed with a germ cell tumor (GCT). The “germ cell” is a cell that will become either the egg or the sperm. A germ cell tumor is ...

Gastrointestinal Cancer, Liver Cancer

Microbial Biomarkers for Hepatocellular Carcinoma

This study focuses on patients who are about to begin treatment for advanced liver cancer at Cedars-Sinai. The purpose of the study is to determine how bacteria in the digestive tract could contribute to response ...

Melanoma, Other Skin, Other Urinary, Ovary, Unknown Sites

IMC-F106C in Advanced Cancers

The purpose of this study is to determine the safety and effectiveness of an investigational immunotherapeutic drug called IMC-F106C in multiple cancers (endometrial, ovarian, melanoma, ocular melanoma, triple-negative breast, lung, and bladder cancer) expressing a ...

Leukemia, not otherwise specified

Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL

This study focuses on individuals who have been diagnosed with mixed-phenotype acute leukemia (MPAL). MPAL is a cancer of the white blood cells that occurs in the bone marrow and is a rare form of ...

Melanoma, Soft Tissue

Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Melanoma

Substudies 02A, 02B, and 02C: To assess the safety and tolerability of investigational treatment combinations based on the proportion of participants with adverse events (AEs). Substudies 02A and 02B: To evaluate objective response rate (ORR) as assessed ...